Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients.

Agarwal K, Castells L, Müllhaupt B, Rosenberg WMC, McNabb B, Arterburn S, Camus G, McNally J, Stamm LM, Brainard DM, Mani Subramanian G, Mariño Z, Dufour JF, Forns X.

J Hepatol. 2018 Sep;69(3):603-607. doi: 10.1016/j.jhep.2018.05.039. Epub 2018 Jun 8.

PMID:
29886154
2.

TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis.

Singh HD, Otano I, Rombouts K, Singh KP, Peppa D, Gill US, Böttcher K, Kennedy PTF, Oben J, Pinzani M, Walczak H, Fusai G, Rosenberg WMC, Maini MK.

Sci Rep. 2017 Jul 17;7(1):5514. doi: 10.1038/s41598-017-05845-5.

3.

Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals.

Godbole G, Irish D, Basarab M, Mahungu T, Fox-Lewis A, Thorne C, Jacobs M, Dusheiko G, Rosenberg WM, Suri D, Millar AD, Nastouli E.

BMC Pregnancy Childbirth. 2013 Dec 1;13:222. doi: 10.1186/1471-2393-13-222.

4.

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update.

Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD, Thillainayagam AV, Thomas HC, Wasan H; British Society of Gastroenterology.

Gut. 2012 Dec;61(12):1657-69. doi: 10.1136/gutjnl-2011-301748. Epub 2012 Aug 15.

PMID:
22895392
5.

[What is EBM and what is not?].

Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS.

Neuere Med Wiss Quellen Stud. 2012;22:13-7. German. No abstract available.

PMID:
22530492
6.

Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation.

Fowell AJ, Collins JE, Duncombe DR, Pickering JA, Rosenberg WM, Benyon RC.

Biochem Biophys Res Commun. 2011 Apr 8;407(2):277-82. doi: 10.1016/j.bbrc.2011.02.009. Epub 2011 Feb 15.

PMID:
21300026
7.

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.

Knapp S, Warshow U, Hegazy D, Brackenbury L, Guha IN, Fowell A, Little AM, Alexander GJ, Rosenberg WM, Cramp ME, Khakoo SI.

Hepatology. 2010 Apr;51(4):1168-75. doi: 10.1002/hep.23477.

8.

Renal hepatitis C in the absence of detectable serum or hepatic virus.

Fowell AJ, Sheron N, Rosenberg WM.

Liver Int. 2008 Jul;28(6):889-91. doi: 10.1111/j.1478-3231.2008.01672.x.

PMID:
18647143
9.

Evidence based medicine: what it is and what it isn't. 1996.

Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS.

Clin Orthop Relat Res. 2007 Feb;455:3-5. No abstract available.

PMID:
17340682
10.

Serum markers detect the presence of liver fibrosis: a cohort study.

Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ; European Liver Fibrosis Group.

Gastroenterology. 2004 Dec;127(6):1704-13.

PMID:
15578508
11.

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, Cox S, Little AM, Alexander GJ, Cramp ME, O'Brien SJ, Rosenberg WM, Thomas DL, Carrington M.

Science. 2004 Aug 6;305(5685):872-4.

12.

Rating fibrosis progression in chronic liver diseases.

Rosenberg WM.

J Hepatol. 2003 Mar;38(3):357-60. Review. No abstract available.

PMID:
12586303
13.

The role of hemochromatosis susceptibility gene mutations in protecting against iron deficiency in celiac disease.

Butterworth JR, Cooper BT, Rosenberg WM, Purkiss M, Jobson S, Hathaway M, Briggs D, Howell WM, Wood GM, Adams DH, Iqbal TH.

Gastroenterology. 2002 Aug;123(2):444-9.

PMID:
12145797
14.

Success in treating mild chronic hepatitis C: different outcomes -- new guidelines?

Rosenberg WM.

Eur J Gastroenterol Hepatol. 2002 Jun;14(6):595-7.

PMID:
12072592

Supplemental Content

Loading ...
Support Center